Azenta, Inc.AZTANASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank21
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P21
Within normal range
vs 3Y Ago
-0.2x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
2025-3.60%
2024-7.16%
202323.29%
202222.89%
202139.05%
2020-71.41%
201920.10%
201817.71%
2017-22.64%
2016-1.32%